SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-49.67%
Change (1 year)
Categories
SCYNEXIS (SCYX) Fails to deliver data
Key failure to deliver metrics for SCYNEXIS:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0 M
- Last 3 months FTD volume: $0 M
- Last year FTD volume: $1.32 M
Failures to deliver for SCYNEXIS (SCYX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for SCYNEXIS (SCYX) - since 2020
Volume in USD (price x number of shares), data since 2020SCYNEXIS (SCYX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0 M | -99.6% |
| 2023 | $1.9 M | -14.62% |
| 2022 | $2.22 M | -85.93% |
| 2021 | $15.82 M | 1263.26% |
| 2020 | $1.16 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | N/A | $0 M | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $0.42 M | $4.04 M | 🇺🇸 USA |
 Catalent CTLT | $24 M | $64.42 M | 🇺🇸 USA |
 KemPharm KMPH | $0.53 M | $5.53 M | 🇺🇸 USA |